(Phys.org) —In the search for new antibiotics, researchers are taking an unusual approach: They are developing peptides, short chains of protein building blocks that effectively inhibit a key enzyme of bacterial metabolism. Now, scientists at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) in Saarbrücken, a branch of the Helmholtz Center for Infection Research (HZI), have published their findings and the implications for potential medical application in the scientific journal ACS Chemical Biology.
The road from gene to protein has an important stop along the way: ribonucleic acid, or RNA. This molecule is essentially a "negative copy" of DNA, the cell's hereditary material, and serves as a blueprint for the cell to make proteins, the basic building blocks of life. This "template" is assembled by the enzyme RNA polymerase, whose job it is to read off the information that is stored within the DNA molecule.
Bacterial RNA polymerase consists of several subunits. The core enzyme has to first bind a certain protein molecule called "sigma factor" which essentially allows the enzyme to begin production of the RNA molecule. The sigma factor locates the starting point of the gene to be copied - as soon as its job is done, it once again detaches from the enzyme complex. The next time, the sigma factor and the core enzyme have to bind to each other again. If this is no longer possible, new RNA cannot be synthesized and no more proteins will be made by the cell. Cellular processes come to a complete standstill, and the bacterium dies.
Which is exactly the reason why the point of contact between the sigma factor and the core enzyme represents a potential target for new therapies against bacterial infections. Another feature makes this a particularly attractive target: "Sigma factors are unique to bacteria and are not found in mammalian cells," explains Kristina Hüsecken, Ph.D. student at the HIPS and the publication's first author. "This way, we are able to specifically target the bacteria without putting the body's own cells at risk." Which also means potential side effects are not to be expected.
The drug researchers from Saarbrücken have looked at a range of peptides, short chains of amino acids, capable of inhibiting the polymerase. Their structure corresponds to areas from the binding site of one of the enzyme parts: A perfect fit, the peptides dock either to the core enzyme or to the sigma factor, specifically at the exact location where the counterpart would normally attach to. This way, the components are prevented from combining to form a functional enzyme since the binding site is already occupied. Of the 16 total peptides the researchers examined, one in particular proved especially effective. The peptide called P07 was able to show in further tests that it actually does prevent transcription of DNA to RNA in bacterial cells by interfering with the interaction between sigma and core enzyme.
A number of current antibiotics target bacterial RNA polymerase, among them rifampicin, which was first introduced in the late 1960s. Yet these classic drugs are quickly losing their efficacy, as germs are evolving resistance to them. "Since we're looking at a new mode of action, it won't come to cross resistance, which is a much-feared issue with new antibiotics," says Dr. Jörg Haupenthal, the study's principal investigator. This could be the case with any new substance whose mode of action is similar to that of an antibiotic the bacteria have already evolved resistance to.
Whether or not P07 will be developed into a market-ready drug is something Haupenthal and his colleagues cannot predict. "Even though our research points the way to new and effective antibiotics, actually developing them into full-blown drugs for clinical use requires much additional research," says Haupenthal. As such, the researchers are working at optimizing P07 while also looking for other molecules capable of binding to the same spot on the polymerase enzyme.
Explore further: Scientists unveil 3-D structure of 'molecular machine' that initiates DNA transcription after 3 decades of searching
More information: K. Hüsecken, M. Negri, M. Fruth, S. Boettcher, R.W. Hartmann, J. Haupenthal Peptide-Based Investigation of Escherichia coli RNA Polmerase s(70):Core Interface As Target Site, ACS Chemical Biology, 2013, DOI: 10.1021/cb3005758 dx.doi.org/10.1021/cb3005758
8 hours ago Hi guys, I'm having a bit of difficulty understanding Pourboix diagrams. The biggest problem at the moment is that I don't clearly understand what... 9 hours ago Hi to all, I want to know the temperature after combustion of methane with air. How will i calculate it? Kindly inform me. Regards,... Apr 28, 2013 I am familiar with the equation ?G=?G°+RT ln(Q).But I can't derive it.We have to use the equation to derive nernst equation. So please help. Apr 28, 2013 Hi, can someone please explain to me how I can identify which is the oxidation half and which is the reduction half of a redox reaction. I have read... Apr 27, 2013 I have been urinating into a plastic bottle lately (I will not elaborate why), and have been finding the bottle to hold a vacuum the following... Apr 27, 2013 Can someone outline a comprehensive way to figure out and write all the different isomers of square planar and octahedral single-centre coordination... Oct 18, 2012 An team of Rutgers University scientists led by Richard H. Ebright and Eddy Arnold has determined the three-dimensional structure of the transcription initiation complex, the key intermediate in the process by which cells ...
Jul 21, 2011 Scientists have identified a family of proteins that close a critical gap in an enzyme that is essential to all life, allowing the enzyme to maintain its grip on DNA and start the activation of genes.
Sep 26, 2011 Mitochondria are compartments within cells and have their own DNA. The key protein required for the expression of the genetic information in this DNA is the mitochondrial RNA polymerase enzyme. Its three-dimensional structure ...
Aug 06, 2007 Transcription — the transfer of DNA’s genetic information through the synthesis of complementary molecules of messenger RNA — forms the basis of all cellular activities. Yet little is known about the dynamics of the ...
5 hours ago (Phys.org) —While the natural world is replete with compounds that form the basis of many disease-fighting pharmaceuticals, it is also the case that humans and other mammals produce their own host-defense ...
10 hours ago (Phys.org) —There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause ...
Apr 29, 2013 (Phys.org) —A combined team of researchers from the U.S. and Slovenia has succeeded in creating "origami" type proteins that assemble themselves into three dimensional shapes. As a proof of concept, the ...
Apr 25, 2013 (Phys.org) —Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new ...
Move the slider to adjust rank threshold, so that you can hide some of the comments.
Display comments: newest firstnot rated yet Apr 09, 2013 Possible side effect: We have lots of beneficial bacteria that are susceptible to this antibiotic as they are to old ones.1 / 5 (1) Apr 09, 2013 It may also affect the liver or quickly generate resistance as rifampicin does.Fingers crossed..
(Phys.org) —While the natural world is replete with compounds that form the basis of many disease-fighting pharmaceuticals, it is also the case that humans and other mammals produce their own host-defense ...
(Phys.org) —There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause ...
From methanol to formaldehyde - this reaction is the starting point for the synthesis of many everyday plastics. Using catalysts made of gold particles, formaldehyde could be produced without the environmentally ...
Researchers have found that reusing the by-products of fruit and cereal processing could help promote the sustainability of the food industry, as long as its overall environmental fingerprint is clearly evaluated.
(Phys.org) —A combined team of researchers from the U.S. and Slovenia has succeeded in creating "origami" type proteins that assemble themselves into three dimensional shapes. As a proof of concept, the ...
(HealthDay)—Members of the American Academy of Family Physicians (AAFP) and other medical associations are urging further consideration of Section 9003 of the Patient Protection and Affordable Care Act ...
(HealthDay)—A new study failed to find any evidence to back up a suggested association between Lyme disease and autism spectrum disorders.
In Western Australia, the wet season occurs between December and March and the dry season between May and October. The reversals of prevailing winds in the two season drives the shift from wet to dry and ...
Although eleventh-century Vikings did not have magnetic compasses at their disposal, it is thought that they could determine their orientation at sea using sun-compasses. Sun-compasses use the position of ...
The atoms that make up ordinary matter fall down, so do antimatter atoms fall up? Do they experience gravity the same way as ordinary atoms, or is there such a thing as antigravity?
© Phys.org™ 2003-2013var _comscore = _comscore || [];var csDocDomain = document.location.href; _comscore.push({ c1: "2", c2: "6035753", c3: "6035753", c4: csDocDomain }); (function() { var s = document.createElement("script"), el = document.getElementsByTagName("script")[0]; s.async = true; s.src = (document.location.protocol == "https:" ? "https://sb" : "http://b") + ".scorecardresearch.com/beacon.js"; el.parentNode.insertBefore(s, el);})();
No comments:
Post a Comment